Technology

Ardelyx

$6.96
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (+0.44%) Today
+$0.10 (+1.46%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Ardelyx and other stocks, options, and ETFs commission-free!

About ARDX

Ardelyx, Inc. Common Stock, also called Ardelyx, is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA. The listed name for ARDX is Ardelyx, Inc. Common Stock.

CEO
Michael G. Raab
Employees
88
Headquarters
Fremont, California
Founded
2007
Market Cap
619.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
714.47K
High Today
$6.95
Low Today
$6.80
Open Price
$6.86
Volume
390.48K
52 Week High
$8.82
52 Week Low
$4.22

Collections

ARDX Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, Pre-Market

You May Also Like

STLA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure